IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis

Nature Communications

Volumn 6, Issue , 2015, Pages

  Krause, Petra ^a   Morris, Venetia ^a   Greenbaum, Jason A ^a   Park, Yoon ^a   Bjoerheden, Unni ^a   Mikulski, Zbigniew ^a   Muffley, Tracy ^a   Shui, Jr Wen ^a   Kim, Gisen ^a   Cheroutre, Hilde ^a   Liu, Yun Cai ^a   Peters, Bjoern ^a   Kronenberg, Mitchell ^a   Murai, Masako ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 23; TRANSCRIPTOME; IL10 PROTEIN, MOUSE; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; SALT INTAKE;

BACTERIAL DISEASE; BACTERIUM; GENE EXPRESSION; IMMUNE RESPONSE; INNATE BEHAVIOR; MORTALITY; RODENT;

ARTICLE; BACTERIAL INFECTION; BONE MARROW CELL; CITROBACTER RODENTIUM; CYTOKINE PRODUCTION; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; INFLAMMATORY CELL; INNATE IMMUNITY; LARGE INTESTINE; LYMPHOID CELL; MACROPHAGE; MORTALITY; NONHUMAN; TISSUE INJURY; ADMINISTRATION AND DOSAGE; ANIMAL; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; INBRED MOUSE STRAIN; INTESTINE; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; OSMOTIC PRESSURE; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SALT INTAKE; TH17 CELL; TOXICITY;

BACTERIA (MICROORGANISMS); CITROBACTER RODENTIUM; ESCHERICHIA COLI; MUS;

ANIMALS; BONE MARROW CELLS; CASPASE 1; FEMALE; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTESTINES; MACROPHAGES; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; OSMOTIC PRESSURE; SODIUM CHLORIDE, DIETARY; STRESS, PHYSIOLOGICAL; TH17 CELLS;

EID: 84929192010     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8055     Document Type: Article

References (49)

1. Glocker, E. O. et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033-2045 (2009).
2. Moran, C. J. et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm. Bowel. Dis. 19, 115-123 (2013).
3. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
4. Spencer, S. D. et al. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187, 571-578 (1998).
5. Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310-1316 (2006).
6. Groux, H. et al. A CD4 T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
7. Van Montfrans, C. et al. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model. Gastroenterology 123, 1865-1876 (2002).
8. Asseman, C., Read, S. & Powrie, F. Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J. Immunol. 171, 971-978 (2003).
9. Roers, A. et al. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 200, 1289-1297 (2004).
10. Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558 (2008).
11. Murai, M. et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10, 1178-1184 (2009).
12. Siewe, L. et al. Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur. J. Immunol. 36, 3248-3255 (2006).
13. Pils, M. C. et al. Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur. J. Immunol. 40, 443-448 (2010).
14. Zigmond, E. et al. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 40, 720-733 (2014).
15. Arai, T. et al. Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection. Immunology 85, 381-388 (1995).
16. Greenberger, M. J. et al. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155, 722-729 (1995).
17. Gazzinelli, R. T. et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN- gamma and TNF-alpha. J. Immunol. 157, 798-805 (1996).
18. Dai, W. J., Kohler, G. & Brombacher, F. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 158, 2259-2267 (1997).
19. Vazquez-Torres, A., Jones-Carson, J., Wagner, R. D., Warner, T. & Balish, E. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect. Immun. 67, 670-674 (1999).
20. Dann, S. M. et al. Attenuation of intestinal inflammation in IL-10 deficient mice infected with Citrobacter rodentium. Infect. Immun. 82, 1949-1958 (2014).
21. Reis e Sousa, C. et al. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 11, 637-647 (1999).
22. Suzuki, Y. et al. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164, 5375-5382 (2000).
23. Hunter, C. A. et al. IL- 10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158, 3311-3316 (1997).
24. Mundy, R., MacDonald, T. T., Dougan, G., Frankel, G. & Wiles, S. Citrobacter rodentium of mice and man. Cell. Microbiol. 7, 1697-1706 (2005).
25. Eckmann, L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann. NY Acad. Sci. 1072, 28-38 (2006).
26. Bhinder, G. et al. The Citrobacter rodentium mouse model: studying pathogen and host contributions to infectious colitis. J. Vis. Exp. e50222 (2013).
27. Gately, M. K. et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16, 495-521 (1998).
28. Cooper, A. M. & Khader, S. A. IL-12p40: an inherently agonistic cytokine. Trends. Immunol. 28, 33-38 (2007).
29. Satpathy, A. T. et al. Notch2- dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat. Immunol. 14, 937-948 (2013).
30. Shui, J. W. et al. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 488, 222-225 (2012).
31. Hunter, C. A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521-531 (2005).
32. Manta, C. et al. CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol. 6, 177-188 (2012).
33. Sulahian, T. H. et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 12, 1312-1321 (2000).
34. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G. & de Vries, J. E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220 (1991).
35. Saraiva, M. & O'Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181 (2010).
36. Kamada, N. et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science New York, NY 336, 1325-1329 (2012).
37. Denning, T. L., Wang, Y. C., Patel, S. R., Williams, I. R. & Pulendran, B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8, 1086-1094 (2007).
38. Ueda, Y. et al. Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10. Int. Immunol. 22, 953-962 (2010).
39. Medina-Contreras, O. et al. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J. Clin. Invest. 121, 4787-4795 (2011).
40. Rivollier, A., He, J., Kole, A., Valatas, V. & Kelsall, B. L. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209, 139-155 (2012).
41. Uhlig, H. H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309-318 (2006).
42. Hue, S. et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203, 2473-2483 (2006).
43. Wiekowski, M. T. et al. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166, 7563-7570 (2001).
44. Hoshi, N. et al. MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice. Nat. Commun. 3, 1120 (2012).
45. Shouval, D. S. et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity 40, 706-719 (2014).
46. Sakuraba, A. et al. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology 137, 1736-1745 (2009).
47. Murai, M. et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat. Immunol. 4, 154-160 (2003).
48. Park, Y. et al. TSC1 regulates the balance between effector and regulatory T cells. J. Clin. Invest. 123, 5165-5178 (2013).
49. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome. Biol. 5, R80 (2004).